HOME >> BIOLOGY >> NEWS
JCI table of contents: June 21, 2007

study appearing online on June 21 in advance of publication in the July print issue of the Journal of Clinical Investigation, Kohichi Tanaka and colleagues from Tokyo Medical and Dental University investigated IOP-independent mechanisms involved in the development of glaucoma. They show that mice deficient in the glutamate transporters GLAST or EAAC1 have spontaneous optical nerve degeneration without elevated IOP. In GLAST-deficient mice, administration of a glutamate receptor blocker prevented optical damage. These animals are believed to be the first animal models of NTG and offer a powerful system for further investigation of retinal degeneration in NTG and the development of therapies directed at preventing or treating IOP-independent glaucoma.

Title: The potential role of glutamate transporters in the pathogenesis of normal tension glaucoma

Author Contact:

Kohichi Tanaka
Tokyo Medical and Dental University, Tokyo, Japan.
Phone : 81-3-5803-5846; Fax:81-3-5803-5843; E-mail: tanaka.aud@mri.tmd.ac.jp

View the PDF of this article at: http://www.the-jci.org/article.php?id=30178


Cardiology

New mouse model for the study of some forms of human hypertension

The angiotensin II receptor, type 1 (AT1) helps control blood pressure; its loss reduces blood pressure, while its overexpression leads to an increase in blood pressure. In a study appearing online on June 21 in advance of publication in the July print issue of the Journal of Clinical Investigation, Eric Clauser and colleagues from Institute Cochin in Paris show that a mutation in AT1 that makes the receptor more sensitive to angiotensin II and the effects of its ligand longer lasting, causes a modest increase in blood pressure, as well as cardiac, vascular, and renal fibrosis, and cardiac dysfunction in mice. This new animal mod
'"/>

Contact: Brooke Grindlinger
press_releases@the-jci.org
212-342-9006
Journal of Clinical Investigation
21-Jun-2007


Page: 1 2 3 4 5 6 7

Related biology news :

1. Antioxidant overload may underlie a heritable human disease
2. JCI table of contents: Aug. 9, 2007
3. JCI table of contents: August 1, 2007
4. US Department of Defense awards $1.6 million for implantable biochip research
5. More fish oil, less vegetable oil, better for your health
6. JCI table of contents -- July 26, 2007
7. JCI table of contents: July 19, 2007
8. JCI table of contents: July 12, 2007
9. JCI table of contents: June 14, 2007
10. Food safety begins as vegetables grow
11. Turning the tables in chemistry

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/21/2020)... ... 2020 , ... Sentien Biotechnologies, Inc., a clinical-stage biotechnology company ... Drug Administration (FDA) has approved the company’s Investigational New Drug (IND) application for ... Approval of this IND allows Sentien to initiate a Phase 1/2 study with ...
(Date:8/12/2020)... Mich. (PRWEB) , ... August 11, 2020 , ... ... R&D subsidiary based in Princeton, NJ, have entered into license agreements with Housey ... and development. Both Roche and J&J have annual Research and Development spending ...
(Date:8/5/2020)... ... 05, 2020 , ... Regenative Labs has received approval from the Centers for ... them the first Wharton’s jelly allografts to be assigned a Q code and be ... the first Wharton’s jelly allograft product to be recognized as a 361 HCT/P by ...
Breaking Biology News(10 mins):
(Date:7/10/2020)... ... 2020 , ... Bode Technology, a leading provider ... through its COVID-19 testing service, Bode-CARES . Bode-CARES combines high-volume clinical testing ... provides a turnkey solution that includes a comprehensive collection and virus-management program for ...
(Date:7/10/2020)... ... July 09, 2020 , ... Sentien Biotechnologies, ... the hiring of Allen R. Nissenson, M.D., F.A.C.P., as its Chief Medical Officer. ... of Sentien’s lead product, SBI-101. Dr. Nissenson serves as an Emeritus Professor ...
(Date:7/1/2020)... (PRWEB) , ... June 29, 2020 , ... ... year to date growth of 40% in 2020, despite many obstacles created as ... MedShift aims to increase revenue for its partnered medical practices and medical manufacturers ...
(Date:6/28/2020)... ... 2020 , ... The Indoor Lab, a leading provider of sensor solutions for ... types to ensure cleanliness, distancing and occupancy with its patent pending WipeAway™ technology using ... will provide a health performance index system that scores all aspects of compliance similar ...
Breaking Biology Technology:
Cached News: